21245. EFGARTIGIMOD PH20 SUBCUTÁNEO (SC) EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA (MGG) EN ADAPTSC+: ANÁLISIS INTERMEDIO DE CALIDAD DE VIDA (QOL), EFICACIA, TOLERABILIDAD Y S... von Sivera Mascaró, R., Vu, T., F Howard, J., Korobko, D., Smilowski, M., Gistelinck, F., Steeland, S., Noukens, J., Podhorna, J., Li, Y., Utsugisawa, K., Saccà, F., Wiendl, H., L De Beecker, J., Mantegazza, R.

Volltext

P276 Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC von Musick, K., Howard, J., Li, G., Vu, T., Korobko, D., Smilowski, M., Liu, L., Steeland, S., Noukens, J., Van Hoorick, B., Podhorna, J., Li, Y., Utsugisawa, K., Saccà, F., Wiendl, H., De Bleecker, J., Mantegazza, R.

Volltext

Een brief van J. A. Alberdingk-Thijm te Amsterdam, aan Dr. J. Nolet de Brauwere van Steeland te Brussel von Josephus Albertus Alberdingk Thijm

Volltext bestellen

J. Nolet de Brauwere van Steeland

Volltext bestellen

Using a Multicomponent, Collaborative Approach for Source Water Protection von Steeland, Kara

Volltext

Nanobodies as therapeutics: big opportunities for small antibodies von Steeland, Sophie, Vandenbroucke, Roosmarijn E., Libert, Claude

Volltext

A New Venue of TNF Targeting von Steeland, Sophie, Libert, Claude, Vandenbroucke, Roosmarijn E

Volltext

A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? von Vergaelen, Elfi, Schiweck, Carmen, Van Steeland, Kristof, Counotte, Jacqueline, Veling, Wim, Swillen, Ann, Drexhage, Hemmo, Claes, Stephan

Volltext

Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease von Steeland, Sophie, Gorlé, Nina, Vandendriessche, Charysse, Balusu, Sriram, Brkic, Marjana, Van Cauwenberghe, Caroline, Van Imschoot, Griet, Van Wonterghem, Elien, De Rycke, Riet, Kremer, Anneke, Lippens, Saskia, Stopa, Edward, Johanson, Conrad E, Libert, Claude, Vandenbroucke, Roosmarijn E

Volltext

TNFR1 inhibition with a Nanobody protects against EAE development in mice von Steeland, Sophie, Van Ryckeghem, Sara, Van Imschoot, Griet, De Rycke, Riet, Toussaint, Wendy, Vanhoutte, Leen, Vanhove, Christian, De Vos, Filip, Vandenbroucke, Roosmarijn E., Libert, Claude

Volltext

Choroid plexus tumor necrosis factor receptor 1 : a new neuroinflammatory piece of the complex Alzheimer's disease puzzle von Steeland, Sophie, Vandenbroucke, Roosmarijn

Volltext

A Study of Cecal Ligation and Puncture-Induced Sepsis in Tissue-Specific Tumor Necrosis Factor Receptor 1-Deficient Mice von Vandewalle, Jolien, Steeland, Sophie, Van Ryckeghem, Sara, Eggermont, Melanie, Van Wonterghem, Elien, Vandenbroucke, Roosmarijn E, Libert, Claude

Volltext

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis von Howard, Jr, James F, Bril, Vera, Vu, Tuan, Karam, Chafic, Peric, Stojan, De Bleecker, Jan L, Murai, Hiroyuki, Meisel, Andreas, Beydoun, Said R, Pasnoor, Mamatha, Guglietta, Antonio, Van Hoorick, Benjamin, Steeland, Sophie, T'joen, Caroline, Utsugisawa, Kimiaki, Verschuuren, Jan, Mantegazza, Renato

Volltext

Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study (P10-11.00... von Howard, James, Li, Yuebing, Vu, Tuan, Korobko, Denis, Steeland, Sophie, Van Hoorick, Benjamin, Podhorna, Jana, Hodari, Moana, Utsugisawa, Kimiaki, Sacca, Francesco, Wiendl, Heinz, De Bleecker, Jan, Mantegazza, Renato

Volltext

A new venue of TNF targeting von Steeland, Sophie, Libert, Claude, Vandenbroucke, Roosmarijn

Volltext

Choroid plexus tumor necrosis factor receptor 1: A new neuroinflammatory piece of the complex Alzheimer's disease puzzle von Steeland, Sophie, Vandenbroucke, Roosmarijn

Volltext

Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1 von Steeland, Sophie, Puimège, Leen, Vandenbroucke, Roosmarijn E., Van Hauwermeiren, Filip, Haustraete, Jurgen, Devoogdt, Nick, Hulpiau, Paco, Leroux-Roels, Geert, Laukens, Debby, Meuleman, Philip, De Vos, Martine, Libert, Claude

Volltext

Glucocorticoid‐induced microRNA‐511 protects against TNF by down‐regulating TNFR1 von Puimège, Leen, Van Hauwermeiren, Filip, Steeland, Sophie, Van Ryckeghem, Sara, Vandewalle, Jolien, Lodens, Sofie, Dejager, Lien, Vandevyver, Sofie, Staelens, Jan, Timmermans, Steven, Vandenbroucke, Roosmarijn E, Libert, Claude

Volltext

Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study (P1-5.014) von Howard, James, Li, George, Vu, Tuan, Korobko, Denis, Smilowski, Marek, Liu, Li, Steeland, Sophie, Noukens, Jan, Van Hoorick, Benjamin, Podhorna, Jana, Li, Yuebing, Utsugisawa, Kimiaki, Sacca, Francesco, Wiendl, Heinz, De Bleecker, Jan, Mantegazza, Renato

Volltext

Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis (P1-5.017) von Li, George, Li, Yuebing, Vu, Tuan, Korobko, Denis, Smilowski, Marek, Liu, Li, Steeland, Sophie, Van Hoorick, Benjamin, Podhorna, Jana, Casey, Jenna, Noukens, Jan, Van Bragt, Tonke, Utsugisawa, Kimiaki, Wiendl, Heinz, De Bleecker, Jan, Mantegazza, Renato, Howard, James

Volltext